Lifshitz & Miller LLP Announces Investigation of Acorda Therapeutics, Inc., Alkermes plc, ASB Financial Corp., CalAtlantic Grou

 Lifshitz & Miller LLP Announces Investigation of Acorda Therapeutics, Inc.,
   Alkermes plc, ASB Financial Corp., CalAtlantic Group, Capella Education
             Company, INC Research Holdings, Inc. and YuMe, Inc.

PR Newswire

NEW YORK, Nov. 16, 2017

NEW YORK, Nov. 16, 2017 /PRNewswire/ --

Acorda Therapeutics, Inc. (ACOR)

Lifshitz & Miller announces an investigation on behalf of ACOR investors
concerning whether ACOR issued false and misleading statements about its Phase
3 trial of tozadenant after 5 patient deaths.

If you are an ACOR investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Alkermes plc (ALKS)

Lifshitz & Miller announces an investigation on behalf of ALKS investors
concerning whether ALKS issued false and misleading statements about its sales
practices for its opioid-addiction-treatment Vivitrol.

If you are an ALKS investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ASB Financial Corp. (ASBN)

Lifshitz & Miller announces investigation into possible breaches of fiduciary
duties by the board in connection with the proposed sale of ASBN to Peoples
Bancorp in which ASBN shareholders will receive for each ASBN share either
$20.00 in cash or 0.592 shares of Peoples Bancorp.

If you are an ASBN investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

CalAtlantic Group (CAA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary
duties by the board in connection with the proposed sale of CAA to Lennar
Corporation in which CAA shareholders will receive either $48.26 in cash,
0.885 Lennar shares, or a combination of both, for each share of CAA owned.

If you are a CAA investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Capella Education Company (CPLA)

Lifshitz & Miller announces investigation into possible breaches of fiduciary
duties by the board in connection with the proposed sale of CPLA to Strayer
Education in which CPLA shareholders will receive 0.875 Strayer shares for
each CPLA share.

If you are a CPLA investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

INC Research Holdings, Inc. (INCR)

Lifshitz & Miller announces an investigation on behalf of INCR investors
concerning whether INCR issued false and misleading statements related to the
inventive Health merger.

If you are an INCR investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

YuMe, Inc. (YUME)

Lifshitz & Miller announces investigation into possible breaches of fiduciary
duties by the board in connection with the proposed sale of YUME to RhythmOne
affiliates in which YUME shareholders will receive $1.70 in cash and 7.325
RhythmOne shares for each YUME share.

If you are a YUME investor, and would like additional information about our
investigation, please complete the Information Request Form or contact Joshua
Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible
for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite
209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not
guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

View original
content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-acorda-therapeutics-inc-alkermes-plc-asb-financial-corp-calatlantic-group-capella-education-company-inc-research-holdings-inc-and-yume-inc-300558277.html

SOURCE Lifshitz & Miller

Website: https://www.jlclasslaw.com
Press spacebar to pause and continue. Press esc to stop.